ES511169A0 - Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos - Google Patents

Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos

Info

Publication number
ES511169A0
ES511169A0 ES511169A ES511169A ES511169A0 ES 511169 A0 ES511169 A0 ES 511169A0 ES 511169 A ES511169 A ES 511169A ES 511169 A ES511169 A ES 511169A ES 511169 A0 ES511169 A0 ES 511169A0
Authority
ES
Spain
Prior art keywords
penetrable
preparing
procedure
composition
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511169A
Other languages
English (en)
Other versions
ES8308698A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8308698A1 publication Critical patent/ES8308698A1/es
Publication of ES511169A0 publication Critical patent/ES511169A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES511169A 1981-04-06 1982-04-05 Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos Granted ES511169A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (2)

Publication Number Publication Date
ES8308698A1 ES8308698A1 (es) 1983-10-01
ES511169A0 true ES511169A0 (es) 1983-10-01

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511169A Granted ES511169A0 (es) 1981-04-06 1982-04-05 Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos

Country Status (16)

Country Link
AU (1) AU564570B2 (es)
CA (1) CA1192496A (es)
DE (1) DE3212053A1 (es)
DK (1) DK155882A (es)
ES (1) ES511169A0 (es)
FI (1) FI821123L (es)
FR (1) FR2502951B1 (es)
GB (2) GB2098865B (es)
GR (1) GR75462B (es)
IL (1) IL65424A0 (es)
IT (1) IT8220611A0 (es)
MY (1) MY8600571A (es)
NL (1) NL8201413A (es)
NZ (1) NZ200232A (es)
PT (1) PT74703B (es)
SE (1) SE8202172L (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (es) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
MX9207344A (es) * 1991-12-16 1993-07-01 Alza Corp Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
WO1994008610A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Pharmaceutical emulsion compositions
JPH08507065A (ja) * 1993-02-17 1996-07-30 スミスクライン・ビーチャム・コーポレイション 医薬組成物含有のミクロエマルジョン
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
IN188719B (es) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
NZ512287A (en) * 1998-12-11 2002-12-20 Pharmasolutions Inc Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2004112723A2 (en) * 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
EA010885B1 (ru) 2003-12-08 2008-12-30 Бентли Фармасьютикалз, Инк. Фармацевтические композиции и способы лечения инсулином
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
EP3824296A4 (en) 2018-07-20 2022-04-27 Lipocine Inc. LIVER DISEASE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (es) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
ES8308698A1 (es) 1983-10-01
GB2148711B (en) 1985-12-18
SE8202172L (sv) 1982-10-07
CA1192496A (en) 1985-08-27
FR2502951B1 (fr) 1985-12-06
DE3212053A1 (de) 1982-10-21
FI821123A7 (fi) 1982-10-07
GB2148711A (en) 1985-06-05
GB8408654D0 (en) 1984-05-16
NL8201413A (nl) 1982-11-01
IL65424A0 (en) 1982-07-30
PT74703B (en) 1984-05-30
AU8233482A (en) 1982-10-14
IT8220611A0 (it) 1982-04-06
GB2098865A (en) 1982-12-01
GB2098865B (en) 1985-12-18
FR2502951A1 (fr) 1982-10-08
MY8600571A (en) 1986-12-31
GR75462B (es) 1984-07-20
PT74703A (en) 1982-05-01
AU564570B2 (en) 1987-08-20
NZ200232A (en) 1985-08-16
FI821123A0 (fi) 1982-03-31
DK155882A (da) 1982-12-10
FI821123L (fi) 1982-10-07

Similar Documents

Publication Publication Date Title
ES511169A0 (es) Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos
MX156495A (es) Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
MX161165A (es) Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
AR226377A1 (es) Procedimiento para la obtencion de formulaciones medicamentosas a base de nifedipina
ES554125A0 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
MX161768A (es) Procedimiento para preparar una composicion desinfectante
MX160316A (es) Procedimiento para preparar una composicion terapeutica de accion prolongada a base de hidroxipropilmetilcelulosa
DE3481164D1 (de) Einrichtung fuer die ophthalmologische chirurgie.
ES539432A0 (es) Un procedimiento para preparar un conjugado de proteina fibrinoliticamente activa
ES551467A0 (es) Procedimiento de preparar ingrediente activo para insecticidas
MX161212A (es) Procedimiento para preparar una composicion protectora de la piel
ES538962A0 (es) Procedimiento para preparar composiciones conservantes y desinfectantes a base de hidroperoxidos.
ES528497A0 (es) Procedimiento para la preparacion de una proteina hipocolesterolemicamente activa
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
ES541848A0 (es) Procedimiento para preparar cloruro de carnitino-nitrilo op-ticamente activo
ZA78408B (en) Pharmaceutically active chromone salts
ES545307A0 (es) Procedimiento para preparar una composicion absorbente a base de arcilla.
MX7581E (es) Procedimiento para preparar una composicion farmaceutica a base de famotidina
AR240939A1 (es) Procedimiento para preparar derivados de imidazoquinolina"
ES538649A0 (es) Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos.
ES547658A0 (es) Procedimiento de preparar agentes cosmeticos para el trata- miento de la piel
IT8021542A0 (it) Procedimento per la preparazione di idrossiderivati dell'isopropilammino-pirimidina (attraverso una base minerale).
AR230571A1 (es) Procedimiento para preparar una composicion farmaceutica
MX6899E (es) Procedimiento para la preparacion de una composicion herbicida a base de 2-halogenoacetanilidas
ES550093A0 (es) Procedimiento para preparar una droga de manzanilla